Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Plerixafor Injection 24 mg per 1.2 mL, in a single-dose vial.
Meitheal will offer Plerixafor Injection in a pack of 1 vial.
ABOUT PLERIXAFOR INJECTION
Plerixafor Injection is a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma.
For full prescribing information, please click on the following link.
Learn more about Plerixafor Injection